Amalgamated Financial’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Amalgamated Financial’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$41K	Buy	+2,145	New	+$44.5K	﹤0.01%	2516

Other funds holding IMGO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amalgamated Financial's IMGO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Imago BioSciences, Inc. Common stock (IMGO) in Q1 2022: 2,145 shares worth $41K. The stake represents ﹤0.01% of the portfolio and ranks #2516 among its holdings.

59 funds tracked by Wall St. Rank hold IMGO as of Q1 2022.

Amalgamated Financial held 2,145 shares of Imago BioSciences, Inc. Common stock worth $41K as of Q1 2022.
Imago BioSciences, Inc. Common stock was a new Amalgamated Financial position in Q1 2022.
Imago BioSciences, Inc. Common stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2516 holding.
59 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.